Kotak Institutional Equities recommended a sell on Divi’s Laboratories with a target price of Rs 3025. The company recorded a weakness in the generic APIs which continues to weigh on the overall print, it said.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
